Apolipoprotein E isoform-specific disruption of phosphoinositide hydrolysis:: protection by estrogen and glutathione

被引:15
作者
Cedazo-Mínguez, A [1 ]
Cowburn, RF [1 ]
机构
[1] Karolinska Inst, NEUROTEC, Div Expt Geriatr, NOVUM,KFC, S-14186 Huddinge, Sweden
关键词
Alzheimer's disease; apolipoprotein E; beta-amyloid; phosphoinositide; estrogen; glutathione;
D O I
10.1016/S0014-5793(01)02761-2
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The mechanism(s) by which the E4 isoform of apolipoprotein E (apoE4) influences Alzheimer's disease (AD) are not fully known. We report that apoE4, but not apoE3, disrupts carbachol-stimulated phosphoinositide (PI) hydrolysis in SH-SY5Y neuroblastoma cells. Carbachol responses were also disrupted by beta -amyloid (A beta) (1-42) and apoE4/A beta (1-42) complexes, but not by apoE3/A beta (1-42). Glutathione and estrogen protected against apoE4 and AP(1-42) effects, as wen as those Of H2O2. Estrogen protection was partially blocked by wortmannin, suggesting the involvement of phosphatidylinositol 3-kinase. An apoE4-induced disruption of acetylcholine muscarinic receptor-mediated signalling may explain the lower effectiveness of cholinergic replacement treatments in apoE4 AD patients. Also, the beneficial effect of estrogen in AD may be partially due to its ability to protect against apoE4- and A beta (142)-mediated disruption of PI hydrolysis. (C) 2001 Federation of European Biochemical Societies. Published by Elsevier Science B.V. All rights reserved.
引用
收藏
页码:45 / 49
页数:5
相关论文
共 28 条
[21]   Apolipoprotein E4 stimulates cAMP response element-binding protein transcriptional activity through the extracellular signal-regulated kinase pathway [J].
Ohkubo, N ;
Mitsuda, N ;
Tamatani, M ;
Yamaguchi, A ;
Lee, YD ;
Ogihara, T ;
Vitek, MP ;
Tohyama, M .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (05) :3046-3053
[22]   A mechanism for the neuroprotective effect of apolipoprotein E: Isoform-specific modification by the lipid peroxidation product 4-hydroxynonenal [J].
Pedersen, WA ;
Chan, SL ;
Mattson, MP .
JOURNAL OF NEUROCHEMISTRY, 2000, 74 (04) :1426-1433
[23]   Apolipoprotein E4 allele as a predictor of cholinergic deficits and treatment outcome in Alzheimer disease [J].
Poirier, J ;
Delisle, MC ;
Quirion, R ;
Aubert, I ;
Farlow, M ;
Lahiri, D ;
Hui, S ;
Bertrand, P ;
Nalbantoglu, J ;
Gilfix, BM ;
Gauthier, S .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (26) :12260-12264
[24]   Oxidative insults are associated with apolipoprotein E genotype in Alzheimer's disease brain [J].
Ramassamy, C ;
Averill, D ;
Beffert, U ;
Theroux, L ;
Lussier-Cacan, S ;
Cohn, JS ;
Christen, Y ;
Schoofs, A ;
Davignon, J ;
Poirier, J .
NEUROBIOLOGY OF DISEASE, 2000, 7 (01) :23-37
[25]   Structure, function, and control of phosphoinositide-specific phospholipase C [J].
Rebecchi, MJ ;
Pentyala, SN .
PHYSIOLOGICAL REVIEWS, 2000, 80 (04) :1291-1335
[26]   Combined tacrine and estrogen replacement therapy in patients with Alzheimer's disease [J].
Schneider, LS ;
Farlow, M .
CEREBROVASCULAR PATHOLOGY IN ALZHEIMER'S DISEASE, 1997, 826 :317-322
[27]   Oxidative stress in Alzheimer's disease [J].
Smith, MA ;
Rottkamp, CA ;
Nunomura, A ;
Raina, AK ;
Perry, G .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2000, 1502 (01) :139-144
[28]   A SEVERE LOSS OF CHOLINE-ACETYLTRANSFERASE IN THE FRONTAL-CORTEX OF ALZHEIMER PATIENTS CARRYING APOLIPOPROTEIN EPSILON-4 ALLELE [J].
SOININEN, H ;
KOSUNEN, O ;
HELISALMI, S ;
MANNERMAA, A ;
PALJARVI, L ;
TALASNIEMI, S ;
RYYNANEN, M ;
RIEKKINEN, P .
NEUROSCIENCE LETTERS, 1995, 187 (02) :79-82